Published in
Springer Verlag, Hepatology International, 2(11), p. 188-198
DOI: 10.1007/s12072-017-9788-z
Links
Tools
Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study
Journal article published in 2017 by
Mark S. Sulkowski,
Walford J. Fessel,
Adriano Lazzarin,
Juan Berenguer,
Natalia Zakharova,
Hugo Cheinquer,
Pierre Côté,
Douglas Dieterich,
Adrian Gadano,
Gail Matthews,
Jean-Michel Molina,
Christophe Moreno,
Juan Antonio Pineda,
Federico Pulido 
,
Antonio Rivero
and other authors.
,
Antonio Rivero
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 